Valuation
- Market cap
- —
- Revenue TTM
- $6,711,990
- Net income TTM
- $2,253,709
- PE ratio
- —
- Forward PE
- —
- Profit margin
- 33.58%
- Debt to equity
- —
Trading
- Volume
- 395,500
- Avg volume
- —
- Day's range
- $5.32 – $5.75
- Shares out
- —
- Stochastic %K
- —
- Beta
- —
- Analysts
- Strong Buy
- Price target
- —
Company profile
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen r...
Show more
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over-the-counter, point-of-care testing, and laboratory markets. Anbio Biotechnology was incorporated in 2021 and is based in Frankfurt am Main, Germany.
- Industry
- Medical Instruments & Supplies
- Sector
- Healthcare
- Phone
- 49 698 7003 9170
- Website
- https://www.anbiobiotechnology.com
- Address
- Friedrich-Ebert-Anlage 35-37, Frankfurt am Main, Germany
Latest news
No headlines yet.
Stocktwits
Sb_invest
Sep 24, 2:27 PM
If
$NNNN hits the scanners and volume comes in, this could go to
$8+
kp8claw
Sep 23, 3:22 PM
$NNNN |
$6.65 | Vol: 300K | RE·RVOL=1.11·F=40M | MUP_5 | Long
0 replies
beolson25
Aug 24, 2:23 PM
$NNNN what's fringin price up today?
0 replies
